These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 241815)

  • 1. ORG 6001 (3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride), a steroidal anti-arrhythmic agent.
    Vargaftig BB; Sugrue MF; Buckett WR; van Riezen H
    J Pharm Pharmacol; 1975 Sep; 27(9):697-9. PubMed ID: 241815
    [No Abstract]   [Full Text] [Related]  

  • 2. Local anaesthetic and antiarrhythmic properties of an aminosteroid: 3alpha-dimethyl-amino-5alpha-androstan-2beta-ol-17-one (Org. NA 13).
    Buckett WR; Marwick FA
    Br J Pharmacol; 1975 May; 54(1):3-9. PubMed ID: 1139075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic, haemodynamic and metabolic effects of 3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride in greyhounds following acute coronary artery ligation.
    Marshall RJ; Parratt JR
    Br J Pharmacol; 1975 Nov; 55(3):359-68. PubMed ID: 1133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of an antiarrhythmic aminosteroid ORG 6001 in the anesthetized pig.
    Verdouw PD; Remme WJ; Beaune J; Rutteman AM; Hagemeijer F
    Arzneimittelforschung; 1976; 26(8):1558-61. PubMed ID: 1036951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic and hemodynamic effects of an aminosteroid (Org 3001) in the digitalized dog.
    Remme WJ; Verdouw PD; Hagemeyer F
    Eur J Pharmacol; 1976 Mar; 36(1):189-97. PubMed ID: 1261591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic, metabolic and hemodynamic effects of Org 6001 (3alpha-amino-5alpha-androstan-2beta-ol-17-one-hydrochloride) after coronary flow reduction in pigs.
    Verdouw PD; Schamhardt HC; Remme WJ; De Jong JW
    J Pharmacol Exp Ther; 1978 Mar; 204(3):634-44. PubMed ID: 633069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations to characterize a new anti-arrhythmic drug, ORG 6001 including a simple test for calcium antagonism.
    Salako LA; Williams V; Wittig JH
    Br J Pharmacol; 1976 Jun; 57(2):251-62. PubMed ID: 7336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antidysrhythmic aminosteroid, ORG 6001, reduces the ST-segment elevation produced by coronary occlusion in the dog.
    Marshall RJ; Parratt JR
    Br J Pharmacol; 1977 Oct; 61(2):315-7. PubMed ID: 922260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an aminosteroid, ORG 6001, on various membrane phenomena of non-myelinated nerve fibres of the rat.
    Kingma JH; Makken R; Hertog AD
    Eur J Pharmacol; 1978 May; 49(1):81-6. PubMed ID: 658128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of potassium canrenoate to suppress ouabain-induced ventricular arrhythmias in dogs.
    Yeh BK; Sung PK; Saha AK
    Circ Res; 1972 Dec; 31(6):915-22. PubMed ID: 4641788
    [No Abstract]   [Full Text] [Related]  

  • 11. Centrogenic cardiac arrhythmia induced by aconitine: a new "model" for screening of anti-arrhythmic drugs.
    Sinha JN; Shamsi MA; Kohli RP; Bhargava KP
    Jpn J Pharmacol; 1971 Dec; 21(6):699-706. PubMed ID: 4401179
    [No Abstract]   [Full Text] [Related]  

  • 12. The antiarrhythmic properties of BL-3677A.
    Buyniski JP; Gardier RW
    J Pharmacol Exp Ther; 1974 Aug; 190(2):289-99. PubMed ID: 4449041
    [No Abstract]   [Full Text] [Related]  

  • 13. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251).
    Torchiana ML; Stone CA; Wenger HC; Evans R; Lagerquist B; O'Malley T
    J Pharmacol Exp Ther; 1975 Aug; 194(2):415-26. PubMed ID: 1151767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent.
    Aisaka K; Hidaka T; Inomata N; Hamasaki S; Ishihara T; Morita M
    Arzneimittelforschung; 1985; 35(8):1239-45. PubMed ID: 4074441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
    Kniffen FJ; Winokur S; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1976 Feb; 196(2):420-32. PubMed ID: 3643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
    Bergey JL; Sulkowski T; Much DR; Wendt RL
    Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiarrhythmic action of 3-carbethoxyamino-5-dimethylaminoacetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS -15) on experimental arrhythmia induced by aconitin, ouabain, calcium chloride and barium chloride].
    Femmer K; Poppe H; Heer S; Bartsch R
    Pharmazie; 1985 Dec; 40(12):836-40. PubMed ID: 3841597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic and electrophysiological effects of CH-200.
    Hashimoto K; Tsukada T; Matsuda H; Imai S
    Eur J Pharmacol; 1977 Sep; 45(2):185-94. PubMed ID: 902689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The specificity of potassium canrenoate, a steroidal antidysrhythmic drug.
    Yeh BK; Sung PK; Lazzara R
    Clin Pharmacol Ther; 1974 Dec; 16(6):1014-22. PubMed ID: 4433469
    [No Abstract]   [Full Text] [Related]  

  • 20. [Actions of sparteine and sparteine derivatives on the heart and circulation].
    Raschack M
    Arzneimittelforschung; 1974 May; 24(5):753-9. PubMed ID: 4408029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.